On the other hand, impaired adaptive immune surveillance occurs in MDS patients with higher risk IPSS scores and in those with AML, with higher levels of Tregs and reduced numbers of CD4 + CD8 + effector memory T-cells, which may contribute to disease progression [49,55,56]. Here, CD4 is linked to myelodysplastic syndrome.